CLLSNasdaqManufacturing

Cellectis S.A. (CLLS) earnings date, market-implied expected move, and options open interest by expiry

1.11

−0.06 · −5.13%

post 1.11 0.00%

Closed16:00 ET

Open1.11Volume12,274Mkt cap$108.4MEPS-0.67

Day1.11 – 1.1150%52-wk0.88 – 5.455%

CLLS

Cellectis S.A.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

News

Next report

Last report

—

Linked news

1dTMO · supplierThermo Fisher EVP Michael D. Shafer to retire effective December 31, 2026
1dAZN · customerAstraZeneca Q3 reported EPS $2.02, total revenue $16,209m; core EPS $2.79

News

Largest filed tie

13F top-10 QoQ

−6.60%

shares held · 10 largest managers

13F · Jun 30 '26123d lag

27 managers

Top fund weight

—

No upcoming report date for Cellectis (CLLS). No implied move.

Implied vs realized

No reported quarters.

Implied vs realized

Positioning

OI · 1 expiry · Oct 19 close

0.00OI · 1 expiry · Oct 19 closeP/C open interest · Feb 19 · nearest expiry

PUTS · chgexpiry · days · P/CCALLS · chgP/C

0—Feb 19111d142+7%

ExpiryPutsCallsP/C

Feb 19111d0—142+7%0.00

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

No filed income statement.

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

FOMC ×2.92· ±10.7% vs ±3.7% · 25 releases

eventrelease day|move|up · n×base

FOMCrate decision±10.7%13 of 25×2.92

NFPjobs report±5.1%3 of 10×1.39

GDPgross domestic product±3.0%9 of 20×0.81

PCEpersonal income & outlays±2.7%9 of 20×0.74

PPIproducer prices±2.5%4 of 11×0.69

CPIconsumer prices±2.4%6 of 11×0.66

CPROFcorporate profits±2.2%5 of 12×0.61

Bar = avg |move| to ±11% · tick = ±3.7% avg day · ×base = |move| ÷ ±3.7% · min 6 releases

Earnings history

No reported quarters.

Methodology

ties · implied moves · holdersMethod